Is NAD+ legal? FDA status and US regulatory standing
Current status
Evaluated, not recommended for compounding. NAD+ was evaluated by the FDA, which proposed that it not be included on the section 503A bulk drug substances list used in pharmacy compounding (status recorded ). NAD+ in injectable form can be lawfully compounded by 503A pharmacies under a valid prescription. Oral NAD+ precursors (NR, NMN) are available as dietary supplements without a prescription. Injectable NAD+ protocols require physician oversight and pharmacy compounding.
Primary source: www.federalregister.gov
Federal legal status
FDA approval status
NAD+ is not FDA-approved as a prescription drug. It is generally recognized as a nutritional supplement precursor (via NR and NMN) when taken orally. Injectable NAD+ has been compounded by licensed pharmacies and is considered legally permissible under current FDA guidance in IV/injection form when prescribed.
Compounding pharmacy rules (federal)
Injectable NAD+ (nicotinamide adenine dinucleotide) can be compounded by licensed 503A pharmacies under a valid prescription. It is not on the 503B bulk substances list but has historically been offered by many compounding pharmacies for IV infusion or subcutaneous injection under physician oversight. Its regulatory status is more permissive than most synthetic peptides.
Also known as
Nicotinamide Adenine Dinucleotide · NAD · β-NAD+
Status history
- NAD+ was evaluated by the FDA, which proposed that it not be included on the section 503A bulk drug substances list used in pharmacy compounding. [source]
About NAD+
NAD+ (nicotinamide adenine dinucleotide) is a coenzyme found in all living cells, central to energy metabolism and DNA repair. Research interest has expanded significantly with studies linking NAD+ decline to aging. Clinical research focuses on replenishment via IV infusion or oral precursors.
Frequently asked questions
- Is injectable NAD+ legal?
- Injectable NAD+ can be legally compounded by licensed 503A compounding pharmacies under a valid physician prescription. It is not FDA-approved as a drug but has a permissive compounding status compared to many synthetic peptides.
- What is the difference between oral NAD+ supplements and IV NAD+?
- Oral supplements typically deliver NAD+ precursors (NR or NMN) which the body converts. IV NAD+ delivers the coenzyme directly into the bloodstream, which proponents claim produces faster and more pronounced effects, though comparative clinical data is limited.
State-level notes
Compounding and prescribing rules are administered by state pharmacy boards and vary by state. Federal FDA status (above) applies nationwide.
Content review: Regulatory status is sourced from the linked primary records and reviewed by the PeptideBase editorial team. This page is educational — not legal or medical advice. Last reviewed: .